Anemia Clinical Trial
Official title:
Nutritional Impact of a Project on Food Security and Nutrition in Children of 6 Months to 5 Years of Age Receiving Home Fortification With Micronutrient Powders in Nariño, Colombia
The effectiveness of micronutrient powders or MNP as a strategy for the prevention of
micronutrient deficiencies has been described in the literature. However, few studies have
shown the impact of the inclusion of other simultaneous actions on the different dimensions
of food and nutritional security (as in the case of the project "Papas más nutritivas") that
will contribute to the improvement of nutritional status, obtaining potentially greater
benefits.
The objective is to establish the existence of difference in hemoglobin values (and other
biochemical parameters as secondary outcomes) among children aged 6 months to 5 years who
receive home fortification with micronutrient powders (MNP) belonging to the project "Papas
más nutritivas", and children with home fortification with MNP but not belonging to the
project.
Micronutrient deficiency is a public health problem. At the national level according to ENSIN
2010, in Colombia the prevalence of anemia in children of 6 to 59 months is 27.5%; of 24.3%
for vitamin A deficiency in children between 1 and 4 years of age; and in the case of zinc
deficiency, the prevalence is of 43.3% of children under 5 years of age. According to FAO and
WHO, different strategies for overcoming micronutrient deficiencies need to be combined and
balanced in order to achieve maximum impact.
The project "Papas más nutritivas" ("Ampliación de la producción de papas amarillas más
nutritivas en Colombia (CIFSRF phase 2) / Scaling up synergetic strategies in agriculture and
nutrition in rural communities of Colombia") funded by the IDRC-International Development
Research Center, through the Canadian International Food Security Research Fund (CISFR) and
implemented by the McGILL University Canada and the Universidad Nacional de Colombia involve,
in addition to the expansion of production of the new varieties of yellow potatoes, other
activities such as Community Schools of Family Agriculture, training schools of leader and
managers in sovereignty and food and nutritional security, strengthening of the shagra (home
garden) and home fortification with micronutrients powders, seeking to improve the quality of
life and nutritional status of families of potato producers for the scope of the food and
nutritional security.
The effectiveness of micronutrient powders or MNP as a strategy for the prevention of
micronutrient deficiencies has been described in the literature. However, few studies have
shown the impact of the inclusion of other simultaneous actions on the different dimensions
of food and nutritional security (as in the case of the project "Papas más nutritivas") that
will contribute to the improvement of nutritional status, obtaining potentially greater
benefits.
Objective: To establish the existence of difference in hemoglobin values among children aged
6 months to 5 years who receive home fortification with micronutrient powders (MNP) belonging
to the project "Papas más nutritivas", and children with home fortification with MNP but not
belonging to the project.
Methodology: Prospective cohort. Two groups are established: the first, children exposed to
the activities of the project "Papas más nutritivas" + MNP (PSAN+MNP group) , and the second,
children exposed only to MNP (MNP group). We will try to include 140 children (70 for each of
the groups), this sample gives us a power of 90% to find a delta of 0.5.
Blood samples will be obtained to evaluate the biochemical parameters: Hemoglobin (determined
by HemoCue), Ferritin, Transferrin, Zinc, vitamin A, C-reactive-ultrasensitive protein,
before MNP fortification and when it finished.
For statistical analysis, a descriptive analysis of both PSAN + MNP and MNP groups will be
carried out on sociodemographic variables, health status and nutritional status. The
continuous variables will be expressed with their measures of central tendency and
dispersion, for the categorical variables absolute and relative frequencies will be used. The
hypothesis of equality of pre and post treatment hemoglobin differences between the groups
(PSAN + MNP versus MNP) will be analyzed using a Student t test or Mann Whitney test,
depending on whether the data follow a normal distribution. A statistically significant p
value corresponding to 0.05 will be considered. The other secondary outcome variables
(vitamin A, zinc, ferritin, transferrin) will be similarly analyzed. In order to control the
systematic differences in the baseline characteristics between the intervention and control
groups, it is proposed to use Propensity Score, which will include the variables of sex, age
and other sociodemographic and nutritional variables considered potentially confusing. The
score of the propensity score model will be used as a covariate in a linear regression model
where it will be adjusted further by the pre-test values of the intervention (ANCOVA). An
unadjusted preliminary analysis (initially described) will be presented and then a new
analysis with the proposed adjustment. An additional analysis will be performed for the
ferritin variable excluding patients with high CRP values.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A |